0000897069-24-000229.txt : 20240131 0000897069-24-000229.hdr.sgml : 20240131 20240131163740 ACCESSION NUMBER: 0000897069-24-000229 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240130 FILED AS OF DATE: 20240131 DATE AS OF CHANGE: 20240131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ng George K CENTRAL INDEX KEY: 0001638744 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39531 FILM NUMBER: 24583487 MAIL ADDRESS: STREET 1: C/O SORRENTO THERAPEUTICS, INC. STREET 2: 6042 CORNERSTONE COURT WEST, SUITE B CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Processa Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001533743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 451539785 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7380 COCA COLA DRIVE STREET 2: SUITE 106 CITY: HANOVER STATE: MD ZIP: 21076 BUSINESS PHONE: 443-776-3133 MAIL ADDRESS: STREET 1: 7380 COCA COLA DRIVE STREET 2: SUITE 106 CITY: HANOVER STATE: MD ZIP: 21076 FORMER COMPANY: FORMER CONFORMED NAME: Heatwurx, Inc. DATE OF NAME CHANGE: 20111028 4 1 form4.xml X0508 4 2024-01-30 0001533743 Processa Pharmaceuticals, Inc. PCSA 0001638744 Ng George K C/O PROCESSA PHARMACEUTICALS, INC. 7380 COCA COLA DRIVE, SUITE 106 HANOVER MD 21076 true true Chief Executive Officer false Common Stock 2024-01-30 4 P 0 10000 2.7 A 20000 I By Family Trust Effective on January 22, 2024, Processa Pharmaceuticals, Inc. effected a 20 to 1 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. Reflects that shares previously reported as directly held by the reporting person were held in a trust. /s/ George Ng, by Neda A. Sharifi, as Attorney-in-Fact 2024-01-31